ReviewBioactive materials2026
Real-time sensing-integrated organoid-on-a-chip platforms: Technological progress and emerging biomedical applications.
Review in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As micro-scale 3D tissues self-organized from stem cells, organoids can highly recapitulate the cellular composition and complex spatial architecture of human organs, establishing themselves as pivotal physiological models in biomedical research. Although organoids offer significant advantages in mimicking human physiological structures, traditional monitoring methodologies predominantly rely on destructive endpoint assays, which fail to capture the transient fluctuations inherent in biological processes. To overcome this limitation, we propose the sensing-integrated organoid-on-a-chip, a frontier interdisciplinary platform. This review systematically outlines the comprehensive construction of this platform, focusing on the synergistic integration of microenvironmental engineering and real-time sensing technologies. The article provides an in-depth analysis of real-time monitoring facilitated by high-performance electrical, optical, and mechanical sensors to quantify organoid developmental maturation, metabolic fluctuations, and pathological evolution. We emphasize the application potential of this platform across developmental biology, disease modeling, drug screening, and neuroscience exploration. Furthermore, we discuss the integration of closed-loop feedback regulation systems and artificial intelligence-assisted analysis, while outlining the trajectory of this platform toward clinical precision medicine and industrial standardization. We firmly believe that sensing-integrated organoid-on-a-chip platforms will accelerate the advancement of personalized diagnosis and therapeutics, thereby ushering in a new era of dynamic biomedical research and intelligent healthcare.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.